Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Rialto. Study-provided care at no cost to qualified participants.
Access ulcerative colitis specialists in Rialto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC). The study will last up to 3 years. Participants who complete the 3-year study may continue to receive mirikizumab until it is (outside of this study) in their country or until they meet other discontinuation criteria.
Sponsor: Eli Lilly and Company
Check if you qualify for this ulcerative colitis clinical trial in Rialto, CA
If you're searching for ulcerative colitis treatment options in Rialto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rialto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.